Work

High response rate but significant toxicity with sequential high-dose ifosfamide (I), carboplatin (C), and etoposide (E) with rituximab for relapsed Hodgkin’s (HD) and large cell non-Hodgkin’s lymphoma (NHL)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.6700

Authors: T. C. Shea, D. Rizzieri, D. Gabriel, J. Serody, N. Chao, J. Gockerman, C. Lindley, G. Rey, M. J. Lehman

Institutions: University of North Carolina at Chapel Hill, Duke University, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2590601988

Cites:

Cited by:

Related to: 10